The Prevalence of Thrombocytopenia and Leucopenia Among People Living with HIV/AIDS in Ethiopia: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2021 Sep 20

PMID 34543340

Citations 3

Authors

Habtye Bisetegn

Hussien Ebrahim

Affiliations

Soon will be listed here.

Abstract

Introduction: Thrombocytopenia and leucopenia are frequently encountered hematological disorders among people living with HIV/AIDS. This systematic review and meta-analysis were aimed to indicate the national prevalence of thrombocytopenia and leucopenia among HIV/AIDS patients.

Methods: This systematic review and meta-analysis was conducted following the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. A systematic search was conducted from February 01, 2021 to April 02, 2021 using electronic databases Google Scholar, PubMed, Web of Sciences, Google, EMBASE, SCOPUS and ResearchGate. The quality of the included studies was assessed using Newcastle-Ottawa Quality Assessment Scale (NOS) adapted for cross-sectional studies. Data analysis was done using STATA version 14 using metan commands. Random effect meta-analysis was used to estimate the pooled prevalence of thrombocytopenia and leucopenia among people living with HIV/AIDS in Ethiopia.

Result: Of the 349 initially searched articles, 90 were assessed for eligibility and only 13 articles published from 2014 to 2020 were included in the final meta-analysis. A total of 3854 participants were involved in the included studies. The pooled prevalence of thrombocytopenia was 9.69% (95%CI; 7.40-11.97%). Significant heterogeneity was observed with I2 value of 84.7%. Thrombocytopenia was 11.91% and 5.95% prevalent among HAART naive and HAART exposed HIV/AIDS patients, respectively. The pooled prevalence of leucopenia among HIV/AIDS patients was 17.31% (95%CI: 12.37-22.25%).

Conclusion: This study showed a high prevalence of thrombocytopenia and leucopenia among people living with HIV/AIDS, indicating the necessity of regular screening of HIV seropositive patients for different hematological parameters and providing treatment.

Citing Articles

Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological Status.

Khan N, Verma C, Ali Beg M, Kumar S, Kaushik G, Ahmad H Immunotargets Ther. 2024; 13:691-705.

PMID: 39678140 PMC: 11645950. DOI: 10.2147/ITT.S495295.

Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study.

Usman A, Balogun O, Shuaib B, Musa B, Yusuf A, Ajayi E Infect Chemother. 2024; 55(4):479-489.

PMID: 38183393 PMC: 10771947. DOI: 10.3947/ic.2023.0080.

Diagnostic utility of haematological parameters in predicting the severity of HIV infection in southwestern Ethiopia: a comparative cross-sectional study.

Haile K, Timerga A, Alemayehu M, Mose A BMJ Open. 2023; 13(10):e072678.

PMID: 37852759 PMC: 10603501. DOI: 10.1136/bmjopen-2023-072678.

References

Getaneh Z, Enawgaw B, Engidaye G, Seyoum M, Berhane M, Abebe Z . Prevalence of anemia and associated factors among school children in Gondar town public primary schools, northwest Ethiopia: A school-based cross-sectional study. PLoS One. 2017; 12(12):e0190151. PMC: 5746225. DOI: 10.1371/journal.pone.0190151. View

Tamir Z, Seid A, Haileslassie H . Magnitude and associated factors of cytopenias among antiretroviral therapy naïve Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia. PLoS One. 2019; 14(2):e0211708. PMC: 6373930. DOI: 10.1371/journal.pone.0211708. View

Opie J . Haematological complications of HIV infection. S Afr Med J. 2012; 102(6):465-8. DOI: 10.7196/samj.5595. View

Vannappagari V, Nkhoma E, Atashili J, St Laurent S, Zhao H . Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets. 2011; 22(8):611-8. DOI: 10.3109/09537104.2011.582526. View

Gunda D, Godfrey K, Kilonzo S, Mpondo B . Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study. Malawi Med J. 2017; 29(1):43-52. PMC: 5442491. DOI: 10.4314/mmj.v29i1.9. View

Laksemi D, Suwanti L, Mufasirin M, Suastika K, Sudarmaja M . Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review. Vet World. 2020; 13(4):716-725. PMC: 7245710. DOI: 10.14202/vetworld.2020.716-725. View

Getawa S, Aynalem M, Bayleyegn B, Adane T . The global prevalence of thrombocytopenia among HIV-infected adults: A systematic review and meta-analysis. Int J Infect Dis. 2021; 105:495-504. DOI: 10.1016/j.ijid.2021.02.118. View

Ried K . Interpreting and understanding meta-analysis graphs--a practical guide. Aust Fam Physician. 2006; 35(8):635-8. View

Durandt C, Potgieter J, Mellet J, Herd C, Khoosal R, Nel J . HIV and haematopoiesis. S Afr Med J. 2019; 109(8b):40-45. DOI: 10.7196/SAMJ.2019.v109i8b.13829. View

10.

Fan H, Guo F, Li Y, Li N, Li T . Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients. Chin Med J (Engl). 2015; 128(4):459-64. PMC: 4836247. DOI: 10.4103/0366-6999.151078. View

11.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

12.

Woldeamanuel G, Wondimu D . Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study. BMC Hematol. 2018; 18:9. PMC: 5944097. DOI: 10.1186/s12878-018-0103-6. View

13.

Egger M, Smith G, Phillips A . Meta-analysis: principles and procedures. BMJ. 1998; 315(7121):1533-7. PMC: 2127925. DOI: 10.1136/bmj.315.7121.1533. View

14.

Fekene T, Juhar L, Mengesha C, Worku D . Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study. BMC Hematol. 2018; 18:8. PMC: 5887186. DOI: 10.1186/s12878-018-0102-7. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

16.

Scaradavou A . HIV-related thrombocytopenia. Blood Rev. 2002; 16(1):73-6. DOI: 10.1054/blre.2001.0188. View

17.

Neunert C, Noroozi N, Norman G, Buchanan G, Goy J, Nazi I . Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2014; 13(3):457-64. PMC: 4991942. DOI: 10.1111/jth.12813. View

18.

Gebreweld A, Fiseha T, Girma N, Haileslasie H, Gebretsadik D . Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia. PLoS One. 2020; 15(9):e0239215. PMC: 7491728. DOI: 10.1371/journal.pone.0239215. View

19.

Wondimeneh Y, Muluye D, Ferede G . Prevalence and associated factors of thrombocytopenia among HAART-naive HIV-positive patients at Gondar University Hospital, northwest Ethiopia. BMC Res Notes. 2014; 7:5. PMC: 3916076. DOI: 10.1186/1756-0500-7-5. View

20.

Pandey A, Galvani A . The global burden of HIV and prospects for control. Lancet HIV. 2019; 6(12):e809-e811. DOI: 10.1016/S2352-3018(19)30230-9. View